TickerFactsScreenerDevelopers

4D Molecular Therapeutics, Inc. (FDMT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$36.71M2020: -$50.91M2021: -$69.13M2022: -$86.69M2023: -$75.79M2024: -$134.59M2025: -$109.08M-$109.08M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$109.08M+18.9%
2024-$134.59M-77.6%
2023-$75.79M+12.6%
2022-$86.69M-25.4%
2021-$69.13M-35.8%
2020-$50.91M-38.7%
2019-$36.71M—